Simple methods for direct antibiotic protection of synthetic vascular grafts.
Two simple methods for direct antibacterial protection of synthetic vascular grafts were investigated. In the first protocol the highly protein-bound antibiotics nafcillin (90% protein bound), cefazolin (80%), and cefamandole (70%) were added directly to preclotting blood. Knitted Dacron grafts preclotted in the presence of one of these drugs absorbed significant amounts. Although at high concentrations these antibiotics exhibited anticoagulant effects, significant antibacterial protection was obtained at lower antibiotic levels. Washing treated grafts for 6 hours failed to eliminate the antibacterial activity. Antibiotics remained on the grafts for at least 96 hours. In the second protocol knitted Dacron grafts were soaked in a suspension of silver-pefloxacin, a silver-nalidixic acid analogue with intense antistaphylococcic activity. Using 110Ag-labeled complexes, significant antibiotic activity was documented on the graft after 19 days of washing. Four nafcillin-treated prostheses, six silver-pefloxacin-coated grafts, and 11 control grafts were interposed in the infrarenal aorta of dogs and immediately challenged with an intravenous infusion of 1 X 10(7) Staphylococcus aureus. None of the four nafcillin-treated grafts was infected at 3 weeks. One of the six silver-pefloxacin-coated grafts grew staphylococci, and 9 of 11 controls had positive graft cultures for Staphylococcus when harvested. These studies suggest that prosthetic grafts can be simply coated at the time of implantation with antibiotics selected for appropriate binding and antibacterial characteristics to obtain an infection-resistant prosthesis.
D000818:Animals; D000985:Antisepsis; D001207:Asepsis; D001777:Blood Coagulation; D001807:Blood Vessel Prosthesis; D002435:Cefamandole / Q000494:pharmacology; D002437:Cefazolin / Q000494:pharmacology; D004285:Dogs; D008855:Microscopy, Electron, Scanning; D009254:Nafcillin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000031:analogs & derivatives; D015366:Pefloxacin; D011093:Polyethylene Terephthalates; D011485:Protein Binding; D012834:Silver
D011093:Polyethylene Terephthalates; D015366:Pefloxacin; D009268:Nalidixic Acid; D012834:Silver; D009254:Nafcillin; D002435:Cefamandole; D002437:Cefazolin